Immunological Mechanisms in Cutaneous Adverse Drug Reactions
10.4062/biomolther.2023.170
- Author:
Ai-Young LEE
1
Author Information
1. Department of Dermatology, Dongguk University Ilsan Hospital, Goyang 10326, Republic of Korea
- Publication Type:Review
- From:Biomolecules & Therapeutics
2024;32(1):1-12
- CountryRepublic of Korea
- Language:English
-
Abstract:
Adverse drug reactions (ADRs) are an inherent aspect of drug use. While approximately 80% of ADRs are predictable, immune system-mediated ADRs, often unpredictable, are a noteworthy subset. Skin-related ADRs, in particular, are frequently unpredictable. However, the wide spectrum of skin manifestations poses a formidable diagnostic challenge. Comprehending the pathomechanisms underlying ADRs is essential for accurate diagnosis and effective management. The skin, being an active immune organ, plays a pivotal role in ADRs, although the precise cutaneous immunological mechanisms remain elusive. Fortunately, clinical manifestations of skin-related ADRs, irrespective of their severity, are frequently rooted in immunological processes. A comprehensive grasp of ADR morphology can aid in diagnosis. With the continuous development of new pharmaceuticals, it is noteworthy that certain drugs including immune checkpoint inhibitors have gained notoriety for their association with ADRs.This paper offers an overview of immunological mechanisms involved in cutaneous ADRs with a focus on clinical features and frequently implicated drugs.
